Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Journal of the National Cancer Institute|April 15, 2015
Gemcitabine/dexamethasone/cisplatin vs cytarabine/dexamethasone/cisplatin for relapsed or refractory aggressive-histology lymphoma: cost-utility analysis of NCIC CTG LY.12Matthew C Cheung, Annette E Hay, Michael Crump, et al.
Archives of Osteoporosis|March 2, 2019
Exploring the association between number, severity, location of fracture, and occiput-to-wall distanceChristina Ziebart, Jonathan D Adachi, Maureen C Ashe, et al.
Cancer Medicine|November 15, 2019
Real-world outcomes of FOLFIRINOX vs gemcitabine and nab-paclitaxel in advanced pancreatic cancer: A population-based propensity score-weighted analysisKelvin K W Chan, Helen Guo, Sierra Cheng, et al.
Archives of Osteoporosis|June 28, 2019
Are osteoporotic vertebral fractures or forward head posture associated with performance-based measures of balance and mobility?Christina Ziebart, Jenna C Gibbs, Caitlin McArthur, et al.
Clinical Lung Cancer|January 24, 2017
Real-World EQ5D Health Utility Scores for Patients With Metastatic Lung Cancer by Molecular Alteration and Response to TherapyCatherine Labbé, Yvonne Leung, João Gabriel Silva Lemes, et al.
Journal of Clinical Epidemiology|September 25, 2024
Development of a Canadian Guidance for reporting real-world evidence for regulatory and health-technology assessment (HTA) decision-makingMina Tadrous, Theresa Aves, Christine Fahim, et al.
The Oncologist|April 7, 2019
The Impact of Brain Metastases and Associated Neurocognitive Aspects on Health Utility Scores in EGFR Mutated and ALK Rearranged NSCLC: A Real World Evidence AnalysisGrainne M O'Kane, Jie Su, Brandon C Tse, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 2, 2021
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic LeukemiaMatthew C Cheung, Nicole Mittmann, Carolyn Owen, et al.
International Journal of Epidemiology|February 21, 2012
Cohort profile: the Ontario HIV Treatment Network Cohort Study (OCS)Sean B Rourke, Sandra Gardner, Ann N Burchell, et al.
Eclinicalmedicine|February 21, 2024
Impact on costs and outcomes of multi-gene panel testing for advanced solid malignancies: a cost-consequence analysis using linked administrative dataAlberto Hernando-Calvo, Paul Nguyen, Philippe L Bedard, et al.
Pageof 17